1+ hour, 47+ min ago   (182+ words) The company did not disclose the amount raised or identify the investors. WellFish said the round included participants from Norway, the UK and the European Union, including venture capital firms, family offices and private investors. The financing follows new commercial…...

1+ hour, 50+ min ago   (104+ words) Published on 08/25/2026 at 05:20 pm EDT Health-care companies rose as the biotech sub-sector gathered momentum. Moderna shares rose by more than 9%, and were headed for their largest monthly gain on record, due to enthusiasm about its cancer vaccine. Jazz Pharmaceuticals shares…...

1+ hour, 1+ min ago   (102+ words) The AI startup is likely to top SpaceX’s eye-popping potential revenue estimate. It is s forecasting another year of earnings above $1 billion. Are you smart enough to beat the Quizmaster? As the City Rail Link transforms Auckland’s Midtown, the case…...

2+ hour, 41+ min ago   (611+ words) In Association with ICON Backed by sustained government investment, regulatory reform and growing biotech ecosystems, China, Japan and South Korea are reshaping global drug development and offering valuable lessons for other regions looking to remain competitive. But demand for clinical…...

1+ week, 1+ day ago   (10+ words) Moomoo...

2+ hour, 47+ min ago   (223+ words) Paul Bubny serves as Senior Content Director for Connect Commercial Real Estate, a role to which he brings 16-plus years’ experience covering the commercial real estate industry and 30-plus years in business-to-business journalism. In this capacity, he oversees daily operations…...

2+ hour, 8+ min ago   (163+ words) TradingView Theravance Biopharma reports CYPRESS Phase 3 miss but FDA grants Type C meeting to discuss future trial Theravance Biopharma reported that the Phase 3 CYPRESS study of ampreloxetine missed its primary endpoint but showed biological activity and prompted further FDA discussions....

1+ hour, 48+ min ago   (241+ words) Ziihera can now be used as an initial treatment for all HER2-positive gastroesophageal adenocarcinomas, dramatically expanding the drug’s market potential. Jazz has two blockbuster drugs in its portfolio. Both are in neuroscience in the guise of the epilepsy drug Epidiolex…...

3+ hour, 37+ min ago   (99+ words) Life Sciences IP Review - What makes a life sciences deal stack up for buyers? While promising science draws in buyers, intellectual property determines the price, terms, and viability of an agreement. LSIPR digs into what buyers are looking for—and…...

1+ hour, 43+ min ago   (298+ words) BiomEdit acquires England-based company’s technology and pipeline assets Inside INdiana Business BiomEdit was set up in 2022 by Indianapolis-based Elanco Animal Health and Boston-based Ginkgo Bioworks, a Bill Gates-backed company that programs cells to make everything from food to therapeutics BiomEdit…...